42 Stocks Moving in Thursday's Pre-Market Session

Gainers

• Immutep Limited IMMP rose 99.5% to $4.29 in pre-market trading after the company reported statistically significant survival benefit for key patient groups in the ongoing Phase IIb AIPAC study in metastatic breast cancer.
• SELLAS Life Sciences Group, Inc. SLS shares rose 99.5% to $12.75 in pre-market trading after climbing 73% on Wednesday. SELLAS Life Sciences and 3D Medicines recently reported an Exclusive license agreement for development and commercialization of galinpepimut-S (GPS) and GPS+ in Greater China.
• UTStarcom Holdings Corp. UTSI rose 94.7% to $2.59 in pre-market trading after climbing around 18% on Wednesday.
• Greenwich LifeSciences, Inc. GLSI shares rose 40.1% to $80.00 in pre-market trading. Greenwich LifeSciences shares jumped 998% on Wednesday after the company shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
• Panbela Therapeutics Inc. PBLA rose 39.8% to $5.99 in pre-market trading after jumping 24% on Wednesday. The company recently reported completion of enrollment in Phase 1b trial investigating SBP-101 combo therapy for first line metastatic pancreatic cancer.
• Veru Inc. VERU rose 31.4% to $5.11 in pre-market trading. Veru shares climbed around 20% on Wednesday after the company posted upbeat quarterly sales and expanded oncology drug pipeline.
• Neos Therapeutics, Inc. NEOS rose 28.4% to $0.71 in pre-market trading. Aytu BioScience and Neos Therapeutics reported a merger agreement.
• Silver Spike Acquisition Corp. SSPK rose 23% to $12.90 in pre-market trading.
• Regulus Therapeutics Inc. RGLS rose 17.1% to $1.05 in pre-market trading. Regulus Therapeutics recently announced the closing of a $19.4 million private placement.
• JanOne Inc. JAN rose 16% to $4.80 in pre-market trading after declining over 4% on Wednesday.
• Asana, Inc. ASAN shares rose 15% to $32.50 in pre-market trading after the company reported upbeat Q3 results and issued strong sales guidance. Piper Sandler raised the price target on the stock from $33 to $40.
• Anchiano Therapeutics Ltd. ANCN rose 12.2% to $1.75 in pre-market trading.
• Teligent, Inc. TLGT rose 11.7% to $0.81 in pre-market trading after gaining 10% on Wednesday.
• Qualigen Therapeutics, Inc. QLGN rose 11.5% to $4.35 in pre-market trading after gaining 8% on Wednesday. Qualigen Therapeutics recently appointed Board member Amy Broidrick as EVP, Chief Strategy Officer and also names Sidney Emery, Jr. to its Board.
• Hoth Therapeutics, Inc. HOTH rose 11.5% to $1.84 in pre-market trading.
• 17 Education & Technology Group Inc. YQ rose 11.2% to $22.45 in pre-market trading following a 34% surge in the previous session. 17 Education & Technology Group, on Friday, priced its 27.4 million ADS at $10.50 per ADS.
• BiomX Inc. PHGE rose 11.2% to $6.65 in pre-market trading as the company announced presentation of preclinical results of analysis of patient samples and engineering of phage for therapeutic applications in colorectal cancer.
• Progenity, Inc. PROG rose 10.1% to $3.82 in pre-market trading.
• Editas Medicine, Inc. EDIT rose 9.5% to $55.38 in pre-market trading after the company reported submission of investigational new drug application for EDIT-301 for sickle cell.
• Celsion Corporation CLSN rose 9% to $0.77 in pre-market trading after surging over 12% on Wednesday.
• InflaRx N.V. IFRX rose 8.8% to $5.22 in pre-market trading.
• 111, Inc. YI rose 8.4% to $7.00 in pre-market trading.
• ObsEva SA OBSV rose 8.1% to $2.26 in pre-market trading after the company reported additional Phase 3 PRIMROSE 1 and 2 study results confirming sustained efficacy and continued safety of linzagolix in the treatment of uterine fibroids.
• Landcadia Holdings II, Inc. LCA rose 7% to $24.56 in pre-market trading after declining 7% on Wednesday.
• C3.ai, Inc. AI shares rose 6.8% to $98.78 in pre-market trading. C3.ai shares climbed 120% on Wednesday after the company priced its 15.5 million share IPO at $42 per share.
• Kaixin Auto Holdings KXIN shares rose 6% to $4.23 in pre-market trading after declining over 9% on Wednesday.
• Starbucks Corporation SBUX rose 4.1% to $104.49 in pre-market trading after the company reaffirmed its guidance for FY21 at an investor event. The company also said it expects FY23 and FY24 adjusted EPS growth of 10% to 12% year over year. Starbucks also announced plans to launch a shaken iced espresso and oat milk this spring in its stores in the US.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Oncternal Therapeutics, Inc. ONCT fell 24% to $4.79 in pre-market trading after climbing 24% on Wednesday. Oncternal Therapeutics, earlier during the week, announced updated interim clinical data from the ongoing Phase 1/2 CIRLL clinical trial.
• GeoVax Labs, Inc. GOVX fell 18.9% to $4.65 in pre-market trading after surging 79% on Wednesday.
• Obalon Therapeutics, Inc. OBLN fell 14.8% to $1.41 in pre-market trading after declining 16% on Wednesday.
• Xenetic Biosciences, Inc. XBIO shares fell 12.6% to $2.77 in pre-market trading. Xenetic Biosciences shares jumped 193% on Wednesday after the company's partner PJSC Pharmsynthez announced data from its Phase 3 study of PolyXen in chronic kidney disease.
• AquaBounty Technologies, Inc. AQB shares fell 12% to $7.63 in pre-market trading after the company announced a common stock offering.
• Intec Pharma Ltd NTEC fell 11.6% to $4.10 in pre-market trading. Intec Pharma shares jumped 34% on Wednesday after the company announced a cannabinoid research collaboration with GW Pharma.
• ZW Data Action Technologies Inc. CNET fell 11.3% to $1.80 in pre-market trading. ZW Data Action Technologies shares jumped 39% on Wednesday after the company announced the opening of its first live streaming platform in Guangzhou, China.
• Francesca's Holdings Corporation FRAN fell 11% to $2.50 in pre-market trading. Francescas shares jumped 23% on Wednesday after the company obtained interim approval to access $15 million of debtor-in-possession financing to facilitate its sale process.
• Genetic Technologies Limited GENE fell 9.2% to $4.06 in pre-market trading after surging over 31% on Wednesday. Genetic Technologies, last week, entered into a three-year partnership with Taliaz for distribution rights to PREDICTIX products in US, New Zealand and Australia.
• Naked Brand Group Limited NAKD fell 8.9% to $0.1585 in pre-market trading after declining around 7% on Wednesday.
• Lexicon Pharmaceuticals, Inc. LXRX shares fell 8.3% to $2.66 in pre-market trading. Citigroup, on Tuesday, upgraded the stock from Neutral to Buy and raised its price target from $2.1 to $6 per share.
• Recon Technology, Ltd. RCON fell 8% to $1.62 in pre-market trading after surging 24% on Wednesday.
• Aptorum Group Limited APM shares fell 7.8% to $2.50 in pre-market trading after declining around 5% on Wednesday.
• Check-Cap Ltd. CHEK shares fell 7.6% to $0.3511 in pre-market trading after gaining 7% on Wednesday.
• Qiwi plc. QIWI fell 7% to $12.65 in pre-market trading.